Alzheimer’s disease Pathophysiology and Disease Mechanisms

Alzheimer’s disease is a progressive dementia with loss of neurons and the presence of two main microscopic neuropathological hallmarks: extracellular amyloid plaques and intracellular neurofibrillary tangles. Early onset AD, a rare familial form, is caused due to mutation of one out of three genes: (amyloid precursor protein), (presenilin 2) or (presenilin 1).  Sporadic form occurs usually after age of 65 and accounts for most cases; it most likely results from a combination of genetic and influence of environment. Confirmed risk factors for sporadic AD are age and the presence of the E4 allele of (Apo lipoprotein E). Amyloid plaques comprise mainly of the neurotoxic peptide amyloid (Aβ, Abeta), cleaved sequentially from a larger precursor protein (APP) by two enzymes: β-secretase (also called BACE1) and γ-secretase (comprising four proteins, presenilin is one of them). If APP is first cleaved by the enzyme α-secretase rather than β-secretase then Aβ is not formed. Neurofibrillary tangles comprise mainly of the protein tau which binds with microtubules, which facilitating the neuronal transport system. Tau uncoupling from microtubules and aggregation into tangles inhibits transport and results in disassembly of microtubule. Phosphorylation of tau might have an important role in this. Selective vulnerability of neuronal systems such as the cholinergic, serotonergic, and noradrenergic and glutamatergic systems form the basis of current rational pharmacological treatment.

This session includes Aging, Prions and Alzheimer’s disease, Cellular signaling and cell to cell transmission, Oxidative damage and mitochondrial dysfunction, Autoimmunity in Alzheimer’s, Blood-brain barrier and transport, Neurogenesis and stem cells and Cell death.

  • Stem cells and Cell death
  • Cellular signalling, kinases, phosphatases, calcium
  • Pathogenesis Of Diabetic Nephropathy
  • Tau Pathology of Alzheimers Disease
  • Pathogenesis of Alzheimers Disease

Related Conference of Alzheimer’s disease Pathophysiology and Disease Mechanisms

September 26-27, 2018

28th World Summit on Neurology, Neuroscience and Neuropharmacology

Montreal, Quebec, Canada
October 18-19, 2018,

27th International Conference on Neurology and Cognitive Neuroscience

Radisson Blu Sobieski Hotel, Warsaw, Poland
November 1-2, 2018

4th International Conference on Spine Surgery

Brussels, Belgium
November 12-13, 2018

5th Annual Conference on Stroke and Neurological Disorders

Istanbul, Turkey
November 12-13, 2018

International conference on Dual Diagnosis and Disorders

Melbourne, Australia
November 12-13, 2018

30th International Conference on Mental and Behavioral Health

Melbourne, Australia
November 12-13, 2018

25th Cognitive Neuroscience Congress

Dubai, UAE
November 16-17, 2018

4th World Congress on Epilepsy and Treatment

Tokyo, Japan
November 16-17, 2018

18th Global Neuroscience Conference

Tokyo, Japan
November 19-20, 2018

8th International Congress on Stroke and Neurology

Paris | France
November 22-23, 2018

World Congress on Epilepsy and Brain Disorders

Cape Town, South Africa
November 26-27, 2018

World Neuron Congress

Helsinki, Finland
December 5-7, 2018

World Brain Congress

Dubai, UAE
December 13-15, 2018

13th Annual Conference on Dementia and Alzheimers Disease

Abu Dhabi, UAE
February 15-16, 2019

11th International Conference on Vascular Dementia

Amsterdam| Netherlands
February 28 – March 02, 2019

28th World Congress on Neurology and Therapeutics

Berlin, Germany
March 14-15, 2019

Annual Congress on Neurology & Neuroscience

Paris, France
March 18-19, 2019

World Depression Congress

Dubai, UAE
March 20-21, 2019

11th World Congress on Alzheimers Disease & Dementia

Sydney, Australia
March 25-26, 2019

8th International Conference on Psychoneuroimmunology

Bucharest, Romania
March 25-26, 2019

31st World Congress on Neurology & Neuroscience

Osaka, Japan
April 11-12, 2019

International Conference on Neurology & Mental Disorders

Stockholm, Sweden
April 22-23, 2019

26th World Congress on Neurology and Neurodisorders

| Radisson Hotel Narita, Tokyo, Japan
May 23-24, 2019

28th World Congress on Neurology & Neuroscience

Zurich, Switzerland
June 17-18, 2019

9th International Conference on Addictive Disorders and Alcoholism

Novotel Brisbane, Australia
June 21-22, 2019

American Neuroscience and Neurosurgery Congress

Ottawa, Canada
July 22-23, 2019

World Congress on Down Syndrome, Autism & Cerebral Palsy

Melbourne, Australia
July 22-24, 2019

32nd European Neurology Congress

London, UK
August 19-20, 2019

5th International Conference on Epilepsy & Treatment

Vienna, Austria
August 19-20, 2019

5th World Congress on Parkinsons & Huntington Disease

Vienna, Austria
October 21-22, 2019

World Congress on Advances in Brain Injury, Disorders and Therapeutics

| Radisson Hotel Narita, Tokyo, Japan
November 19-20, 2019

32nd Clinical Neuroscience and Neurogenetics Conference

Istanbul, Turkey

Alzheimer’s disease Pathophysiology and Disease Mechanisms Conference Speakers

Recommended Sessions

Related Journals

Are you interested in